Arthritis sufferers will soon have a new over-the-counter treatment option.
Voltaren Arthritis Pain, a nonsteroidal anti-inflammatory topical gel, has been approved for over-the-counter sales by the United States Food and Drug Administration. The drug is the first prescription strength NSAID topical gel for arthritis.
It has been available by prescription since the FDA first approved it in 2007.
Nearly 30 million Americans are living with osteoarthritis. Voltaren is indicated for temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults 18 years and older.
Voltaren will be available over the counter in the coming months.
the International Society for Osteoarthritis Research also updated its guidelines for the nonsurgical management of osteoarthritis to include a strong recommendation for the use of topical nonsteroidal anti-inflammatory drugs in people with osteoarthritis of the knee due to its consistent effectiveness and its minor side effects.
The FDA approval of Voltaren was based on clinical data used for GlaxoSmithKline’s original prescription approval, which demonstrated substantial pain relief within the first week of use. It is not indicated for immediate pain relief.
Alcon’s Pataday Twice Daily Relief and Pataday Once Daily – medicine for red and itchy eyes caused by – allergies also received approval for over-the-counter use.